Merck & Co., Inc.MRKNYSE
Loading
Cash Flow PerformanceNormalizing
Percentile Rank43
3Y CAGR-3.6%
5Y CAGR+9.7%
Studio
Year-over-Year Change

Free cash flow yield

3Y CAGR
-3.6%/yr
vs +4.5%/yr prior
5Y CAGR
+9.7%/yr
Recent deceleration
Acceleration
-8.1pp
Decelerating
Percentile
P43
Within normal range
vs 5Y Ago
1.6x
Solid growth
Streak
1 yr
Consecutive declineNormalizing
PeriodValueYoY Change
20254.68%-34.8%
20247.18%+123.3%
20233.22%-38.6%
20225.24%+5.1%
20214.98%+68.8%
20202.95%-34.1%
20194.48%+1.9%
20184.40%+39.4%
20173.15%-44.5%
20165.68%-